US Patent Issued to Ensysce Biosciences on April 14 for "Compositions comprising enzyme-cleavable prodrugs and controlled release nafamostat and methods of use thereof" (California Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,578, issued on April 14, was assigned to Ensysce Biosciences Inc. (La Jolla, Calif.).

"Compositions comprising enzyme-cleavable prodrugs and controlled release nafamostat and methods of use thereof" was invented by Lynn Kirkpatrick (La Jolla, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Aspects of the present disclosure include pharmaceutical compositions, and their methods of use, where the pharmaceutical compositions include an active agent prodrug that provides enzymatically-controlled release of an active agent, and controlled release nafamostat or a pharmaceutically acceptable salt thereof."

The patent was filed on March 8, 2022, und...